Clinical utility of FDG–PET and PET/CT in non-malignant thoracic disorders

S Basu, B Saboury, T Werner, A Alavi - Molecular imaging and biology, 2011 - Springer
There have been several endeavors made to investigate the potential role of 2-deoxy-2-[18
F] fluoro-D-glucose positron emission tomography (FDG-PET)(and tracers) and PET …

Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose

J Zhu, F Pan, H Cai, L Pan, Y Li, L Li, YC Li… - Frontiers in …, 2022 - frontiersin.org
Lung cancer has been the leading cause of cancer-related mortality in China in recent
decades. Positron emission tomography-computer tomography (PET/CT) has been …

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT

M Shiiba, K Ishihara, G Kimura, T Kuwako… - Annals of nuclear …, 2012 - Springer
Objective The objective of this study was to evaluate the capability of 11 C-methionine (MET)-
PET/CT and 18 F-2-deoxy-2-fluoro-d-glucose (FDG)-PET/CT to diagnose primary prostate …

11C-Methionine PET/CT Imaging of 99mTc-MIBI-SPECT/CT-Negative Patients With Primary Hyperparathyroidism and Previous Neck Surgery

T Traub-Weidinger, ME Mayerhoefer… - The Journal of …, 2014 - academic.oup.com
Context: 99mTc-Methoxy-isobutyl-isonitrile (MIBI) scintigraphy is a standard preoperative
localization imaging modality in patients with primary hyperparathyroidism (pHPT). Its …

[HTML][HTML] PET imaging in patients with coal workers pneumoconiosis and suspected malignancy

M Reichert, ES Bensadoun - Journal of Thoracic Oncology, 2009 - Elsevier
Positron Emission Tomography (PET) with F-18-fluorodeoxyglucose is commonly used in
the evaluation of lung nodules; however, there is limited data on the PET appearance of coal …

The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients

EK Choi, HL Park, IR Yoo, SJ Kim, YK Kim - European radiology, 2020 - Springer
Abstract Objectives We reviewed PET/CT findings of pneumoconiosis and determined the
ability of PET/CT to differentiate lung cancer from progressive massive fibrosis (PMF), and …

Alternative and new radiopharmaceutical agents for lung cancer

S Telo, L Calderoni, S Vichi, F Zagni… - Current …, 2020 - ingentaconnect.com
Background: FDG PET/CT imaging has an established role in lung cancer (LC)
management. Whilst it is a sensitive technique, FDG PET/CT has a limited specificity in the …

Clinical Value and Limitations of [11C]-Methionine PET for Detection and Localization of Suspected Parathyroid Adenomas

K Herrmann, T Takei, K Kanegae, T Shiga… - Molecular imaging and …, 2009 - Springer
Purpose The aim of this study was to assess the clinical value of [11 C] methionine-PET
(MET-PET) for detection and localization of parathyroid adenomas in patients without prior …

PET/MRI and PET/CT in lung lesions and thoracic malignancies

P Flechsig, A Mehndiratta, U Haberkorn… - Seminars in nuclear …, 2015 - Elsevier
More than one decade ago, introduction of integrated PET/CT scanners changed oncologic
imaging and oncologic patient management profoundly. With these systems, the metabolic …

Diagnostic usefulness of an amino acid tracer, α-[N-methyl-11C]-methylaminoisobutyric acid (11C-MeAIB), in the PET diagnosis of chest malignancies

R Nishii, T Higashi, S Kagawa, Y Kishibe… - Annals of nuclear …, 2013 - Springer
Objectives Although positron emission tomography (PET) using [18 F]-fluoro-2-deoxy-d-
glucose (18 F-FDG) is established as one of the first-choice imaging modalities in the …